Active Biotech AB (ACTI) - Total Assets

Latest as of September 2025: Skr17.00 Million SEK ≈ $1.83 Million USD

Based on the latest financial reports, Active Biotech AB (ACTI) holds total assets worth Skr17.00 Million SEK (≈ $1.83 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Active Biotech AB to assess the company's total reinvestment commitment from operating cash flow.

Active Biotech AB - Total Assets Trend (2000–2024)

This chart illustrates how Active Biotech AB's total assets have evolved over time, based on quarterly financial data. Check ACTI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Active Biotech AB - Asset Composition Analysis

Current Asset Composition (December 2024)

Active Biotech AB's total assets of Skr17.00 Million consist of 90.7% current assets and 9.3% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr27.39 Million	63.4%
Accounts Receivable	Skr9.50 Million	22.0%
Inventory	Skr0.00	0.0%
Property, Plant & Equipment	Skr3.35 Million	7.8%
Intangible Assets	Skr245.00K	0.6%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Active Biotech AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ACTI market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Active Biotech AB's current assets represent 90.7% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 63.4% of total assets in 2024, up from 11.5% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 5.0% in 2000.
Asset Diversification: The largest asset category is cash and equivalents at 63.4% of total assets.

Active Biotech AB Competitors by Total Assets

Key competitors of Active Biotech AB based on total assets are shown below.

Company	Country	Total Assets
Ascendis Pharma AS NASDAQ:ASND	USA	$2.01 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$8.59 Billion
Spyre Therapeutics Inc. NASDAQ:SYRE	USA	$763.95 Million
3SBio Inc F:83B	Germany	€36.25 Billion
Soleno Therapeutics Inc NASDAQ:SLNO	USA	$608.39 Million
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	China	CN¥4.48 Billion
Novavax Inc NASDAQ:NVAX	USA	$1.04 Billion
BB Biotech AG SW:BION	Switzerland	CHF2.64 Billion

Active Biotech AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.17	0.93	3.24
Quick Ratio	1.17	1.31	3.27
Cash Ratio	0.75	0.54	0.00
Working Capital	Skr2.10 Million	Skr-800.00K	Skr20.93 Million

Active Biotech AB - Advanced Valuation Insights

This section examines the relationship between Active Biotech AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	22.61
Latest Market Cap to Assets Ratio	2.40
Asset Growth Rate (YoY)	-1.9%
Total Assets	Skr43.20 Million
Market Capitalization	$103.60 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Active Biotech AB's assets at a significant premium (2.40x), suggesting investors see substantial growth potential or unique competitive advantages.

Slight Asset Contraction: Active Biotech AB's assets decreased by 1.9% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Active Biotech AB (2000–2024)

The table below shows the annual total assets of Active Biotech AB from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	Skr43.20 Million ≈ $4.65 Million	-1.92%
2023-12-31	Skr44.05 Million ≈ $4.74 Million	-13.64%
2022-12-31	Skr51.01 Million ≈ $5.49 Million	-10.21%
2021-12-31	Skr56.80 Million ≈ $6.11 Million	+76.66%
2020-12-31	Skr32.16 Million ≈ $3.46 Million	-51.97%
2019-12-31	Skr66.95 Million ≈ $7.21 Million	-77.86%
2018-12-31	Skr302.43 Million ≈ $32.55 Million	-0.45%
2017-12-31	Skr303.81 Million ≈ $32.70 Million	-26.42%
2016-12-31	Skr412.88 Million ≈ $44.43 Million	-8.14%
2015-12-31	Skr449.44 Million ≈ $48.37 Million	-37.80%
2014-12-31	Skr722.52 Million ≈ $77.75 Million	-5.90%
2013-12-31	Skr767.81 Million ≈ $82.63 Million	+10.20%
2012-12-31	Skr696.74 Million ≈ $74.98 Million	-18.84%
2011-12-31	Skr858.52 Million ≈ $92.39 Million	+70.65%
2010-12-31	Skr503.10 Million ≈ $54.14 Million	+0.92%
2009-12-31	Skr498.50 Million ≈ $53.65 Million	+5.40%
2008-12-31	Skr472.95 Million ≈ $50.90 Million	-3.39%
2007-12-31	Skr489.54 Million ≈ $52.68 Million	+5.87%
2006-12-31	Skr462.40 Million ≈ $49.76 Million	-18.57%
2005-12-31	Skr567.86 Million ≈ $61.11 Million	+81.49%
2004-12-31	Skr312.89 Million ≈ $33.67 Million	-9.41%
2003-12-31	Skr345.40 Million ≈ $37.17 Million	-26.12%
2002-12-31	Skr467.50 Million ≈ $50.31 Million	-37.48%
2001-12-31	Skr747.74 Million ≈ $80.47 Million	-13.95%
2000-12-31	Skr868.95 Million ≈ $93.51 Million	--

About Active Biotech AB

ST:ACTI Sweden Biotechnology

Market Cap

$1.73 Billion

Skr16.07 Billion SEK

Market Cap Rank

#19136 Global

#330 in Sweden

Share Price

Skr6.10

Change (1 day)

+3.66%

52-Week Range

Skr0.04 - Skr7.20

All Time High

Skr28.53